QingSong Health Statistics

Total Valuation

QingSong Health has a market cap or net worth of HKD 10.60 billion. The enterprise value is 9.54 billion.

Market Cap	10.60B
Enterprise Value	9.54B

Important Dates

The next estimated earnings date is Thursday, June 18, 2026.

Earnings Date	Jun 18, 2026
Ex-Dividend Date	n/a

Share Statistics

QingSong Health has 206.37 million shares outstanding. The number of shares has decreased by -17.96% in one year.

Current Share Class	206.37M
Shares Outstanding	206.37M
Shares Change (YoY)	-17.96%
Shares Change (QoQ)	-57.44%
Owned by Insiders (%)	35.64%
Owned by Institutions (%)	n/a
Float	66.51M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.58
PB Ratio	9.50
P/TBV Ratio	9.69
P/FCF Ratio	117.03
P/OCF Ratio	116.01
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 109.99, with an EV/FCF ratio of 105.31.

EV / Earnings	-22.57
EV / Sales	6.82
EV / EBITDA	109.99
EV / EBIT	116.55
EV / FCF	105.31

Financial Position

The company has a current ratio of 6.36, with a Debt / Equity ratio of 0.00.

Current Ratio	6.36
Quick Ratio	5.95
Debt / Equity	0.00
Debt / EBITDA	0.04
Debt / FCF	0.04
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	4.89%
Return on Invested Capital (ROIC)	151.51%
Return on Capital Employed (ROCE)	7.28%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	6.56M
Profits Per Employee	-1.98M
Employee Count	213
Asset Turnover	1.34
Inventory Turnover	n/a

Taxes

In the past 12 months, QingSong Health has paid 940,325 in taxes.

Income Tax	940,325
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	109.91
200-Day Moving Average	n/a
Relative Strength Index (RSI)	23.02
Average Volume (20 Days)	933,780

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, QingSong Health had revenue of HKD 1.40 billion and -422.56 million in losses. Loss per share was -5.10.

Revenue	1.40B
Gross Profit	484.23M
Operating Income	81.82M
Pretax Income	-421.62M
Net Income	-422.56M
EBITDA	82.29M
EBIT	81.82M
Loss Per Share	-5.10

Full Income Statement

Balance Sheet

The company has 1.07 billion in cash and 3.76 million in debt, giving a net cash position of 1.06 billion or 5.14 per share.

Cash & Cash Equivalents	1.07B
Total Debt	3.76M
Net Cash	1.06B
Net Cash Per Share	5.14
Equity (Book Value)	1.12B
Book Value Per Share	5.40
Working Capital	1.09B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 91.35 million and capital expenditures -796,772, giving a free cash flow of 90.55 million.

Operating Cash Flow	91.35M
Capital Expenditures	-796,772
Depreciation & Amortization	488,204
Net Borrowing	-4.87M
Free Cash Flow	90.55M
FCF Per Share	0.44

Full Cash Flow Statement

Margins

Gross margin is 34.65%, with operating and profit margins of 5.85% and -30.24%.

Gross Margin	34.65%
Operating Margin	5.85%
Pretax Margin	-30.17%
Profit Margin	-30.24%
EBITDA Margin	5.89%
EBIT Margin	5.85%
FCF Margin	6.48%

Dividends & Yields

QingSong Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	17.96%
Shareholder Yield	17.96%
Earnings Yield	-3.99%
FCF Yield	0.85%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

QingSong Health has an Altman Z-Score of 38.51 and a Piotroski F-Score of 5.

Altman Z-Score	38.51
Piotroski F-Score	5